|
CDC42BPB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.718400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.091200E-01 |
| Normal-vs-Stage2 |
8.228000E-01 |
| Normal-vs-Stage3 |
1.492370E-01 |
| Normal-vs-Stage4 |
2.471400E-01 |
| Stage1-vs-Stage2 |
2.103600E-01 |
| Stage1-vs-Stage3 |
5.967000E-01 |
| Stage1-vs-Stage4 |
8.563000E-01 |
| Stage2-vs-Stage3 |
1.262010E-01 |
| Stage2-vs-Stage4 |
2.263600E-01 |
| Stage3-vs-Stage4 |
8.076600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.277800E-01 |
| Normal-vs-AfricanAmerican |
7.316400E-01 |
| Normal-vs-Asian |
3.426000E-01 |
| Caucasian-vs-AfricanAmerican |
3.102400E-01 |
| Caucasian-vs-Asian |
8.658600E-01 |
| AfricanAmerican-vs-Asian |
2.954200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.294580E-01 |
| Normal-vs-Female |
3.787400E-01 |
| Male-vs-Female |
2.982800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.763000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.839760E-01 |
| Normal-vs-Age(61-80Yrs) |
3.135600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.042000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.224600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.296000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.332200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.277400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.735600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.654800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.227000E-01 |
| Classical-VS-Follicular |
7.836300E-03 |
| Classical-VS-Other |
8.915500E-02 |
| Classical-VS-Normal |
7.689000E-01 |
| Tall-VS-Follicular |
3.340600E-01 |
| Tall-VS-Other |
1.755200E-01 |
| Tall-VS-Normal |
4.163800E-01 |
| Follicular-VS-Other |
4.619400E-01 |
| Follicular-VS-Normal |
3.536400E-02 |
| Other-VS-Normal |
4.853500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.153800E-01 |
| Normal-vs-N1 |
5.591800E-02 |
| N0-vs-N1 |
2.483400E-01 |
|
|
